The weight management landscape has evolved—and your pharmacy can now offer the UK's first oral GLP-1 treatment under a fully digital Patient Group Direction.

Following the approval of oral semaglutide for weight loss, we are thrilled to announce the launch of the Wegovy Tablets PGD, live and ready to activate on the Deltera platform.

With needle phobia and injection anxiety remaining major barriers for many weight loss patients, oral Wegovy offers a game-changing alternative. By adding this service to your clinical offering, your pharmacy can unlock a completely new demographic of private weight management clients.

Key Clinical Features of the Wegovy Tablet PGD

Our new protocol is designed for total compliance, patient safety, and seamless consultation flow:

• Full Dose Escalation Pathway: Covers the complete titration protocol—from the initial 1.5mg starting dose through 4mg and 9mg, up to the 25mg maintenance dose.

• Injection-to-Tablet Transition Guidance: Clear clinical pathways for patients transitioning from the weekly injection directly to the daily tablet.

• Built-In Fasting & Dosing Safety Protocols: Prompts to educate patients on the strict morning empty-stomach administration routine required for oral GLP-1 absorption.

• Core Eligibility Guardrails: Automated BMI checks (BMI greater than or equal to 30, or BMI greater than or equal to 27 with at least one weight-related comorbidity).

Seamless Weight Management in One Unified Dashboard

Running a private weight management clinic shouldn't mean fighting with fragmented software or stacks of paper checklists. The Wegovy Tablets PGD integrates natively with your existing Deltera suite:

1. Unified Weight Management Triage

Offer Wegovy injections, Mounjaro, and Wegovy tablets side-by-side. Our intelligent pre-screening forms allow patients to select their preferred administration method (oral vs. injectable) before they even book.

2. Automated Fasting & Lifestyle Triage

Oral semaglutide requires specific daily habits—taking the tablet first thing in the morning with a sip of water, followed by a 30-minute fast. Deltera’s interactive pre-screen logic ensures the patient understands and agrees to these requirements before entering your consultation room.

3. Recurring Revenue via the Patient Portal

Because Wegovy tablets require daily administration and monthly dose step-ups, keeping patients on track is critical for clinical success and pharmacy retention. Through the Deltera Patient Portal, patients receive automated prompts to book their next month's supply, view their clinical notes, and log their weight progress.

4. Integrated Financial Control

Take upfront payments or partial consultation deposits at the point of booking. Eliminate costly no-shows and protect your fridge and shelf stock margins.

How to Activate the Wegovy Tablets PGD

If you are an existing Deltera platform user, the new PGD is available in your PGD library as part of your core subscription at no extra cost.

1. Log into your Deltera Head Office or Branch Dashboard.

2. Navigate to Service Management > PGD Library.

3. Select Wegovy Tablets (Oral Semaglutide) and complete your digital sign-off.

4. Publish your unique booking link directly to your website, social channels, or Google Business Profile.